期刊文献+

2012年河南省人民医院200例肿瘤患者化疗药应用合理性分析 预览 被引量:2

Rationality in The Use of Chemotherapeutic Drugs for Patients with Tumor in Henan Provincial People' s Hospital in 2012 : Analysis of 200 Cases
在线阅读 下载PDF
分享 导出
摘要 目的:了解我院肿瘤患者化疗药使用情况,为临床合理用药提供参考。方法:随机抽取我院2012年200例肿瘤患者化疗病例,对其中不合理用药情况进行点评、分析。结果:共有44例患者存在用药不合理现象,主要表现为适应证不适宜、用药顺序错误、用法与用量不适宜及化疗方案不合理。结论:我院肿瘤患者化疗药不合理使用现象较为普遍,临床药师应及时将点评结果反馈给临床,对不合理用药行为进行干预与提醒,共同促进药物合理使用。 OBJECTIVE : To investigate the use of chemotherapeutic drugs for patients with tumor in our hospital so as to provide reference for clinical rational use of drugs. METHODS : 200 medical records of patients with tumor were randomly sampled in 2012 from our hospital for evaluation and analysis regarding the irrational prescriptions. RESULTS: Irrational drug use was noted in 44 cases, which manifested as improper in indications, wrong order in drug administration, improper in usage & dosage or irrational in chemotherapy regimen. CONCLUSION: The phenomenon of irrational use of chemotherapeutic drugs was very common in our hospital. Clinical pharmacists should timely report the results of prescription comment to clinicians meanwhile providing intervention and warning on their irrational drug use behavior so as to promote rational use of drugs together with clinicians.
作者 赵成龙 赵红卫 柴东燕 王文玉 秦玉花 ZHAO Cheng-long, ZHAO Hong-wei, CHAI Dong-yan, WANG Wen-yu, QIN Yu-hua (Henan Provincial People' s Hospital, Zhengzhou 450003, China)
机构地区 河南省人民医院
出处 《中国医院用药评价与分析》 2013年第11期983-985,共3页 Evaluation and Analysis of Drug-use in Hospitals of China
关键词 化疗药 合理性 分析 Chemotherapeutic drugs Rationality Analysis
作者简介 药师。研究方向:肿瘤内科临床药学。E—mail:zhaocl725@gmail.com
  • 相关文献

参考文献11

  • 1Weissman CH, Reynolds CH, Neubauer MA, et al. A phase Ⅲ randomized trial of gemcitabine-oxaliplatin versus carboplatin-paclitaxel as first-line therapy in patientswith advanced non-small cell lung cancer [ J ]. J Thorac Oncol,2011,6( 2 ) :358-364. 被引量:1
  • 2Atmaca A, A1-Batran SE, Wemer D, et al. A randomised multicentre phase Ⅱ study with cisplatin/doeetaxel vs oxaliplatin/docetaxel as first-line therapy inpatients with advanced or metastatic non-small cell lung cancer[ J]. Br J Cancer, 2013,108 (2) :265-270. 被引量:1
  • 3Raez LE, Kobina S, Santos ES. Oxaliplatin in first-line therapy for advanced non-small-cell lung cancer[ J ]. Clin Lung Cancer ,2010,11 ( 1 ) : 18-24. 被引量:1
  • 4Kuo DY, Blank SV, Christos PJ, et al. Paclitaxel plus oxaliplatin for recurrent or metastatic cervical cancer: a New York Cancer Consortium Study [ J ]. Gynecol Oncol, 2010,116(3) :442-446. 被引量:1
  • 5Nomura H, Aoki D, Takahashi F, et al. Randomized phase Ⅱ study comparing docetaxel plus cisplatin, docetaxel plus carboplatin, and paclitaxel pluscarboplatin in patients with advanced or recurrent endometrial carcinoma: a Japanese Gynecologic OncologyGroup study (JGOG2041)[ J ]. Ann Oncol, 2011,22 ( 3 ) : 636 -642. 被引量:1
  • 6Fracasso PM, Blessing JA, Molpus KL, et al. Phase Ⅱ study of oxaliplatin as second-line chemotherapy in endometrial carcinoma :a Gynecologic Oncology Group study [ J ]. Gynecol 0ncoi,2006,103 ( 2 ) :523-526. 被引量:1
  • 7Rowinsky EK, Gilbert MR, McGuire WP, et al. Sequences of taxol and cisplatin: a phase I and pharmacologic study [ J ]. J Clin Oncol, 1991,9 (9) : 1692-703. 被引量:1
  • 8Qin B, Tanaka R, Shibata Y, et al. In-vitro schedule- dependent interaction between oxaliplatin and 5-fluo- rouracil in human gastric cancer cell lines [ J ]. Anticancer Drugs, 2006,17 ( 4 ) : 445 -453. 被引量:1
  • 9Koizumi W, Kurihara M, Hasegawa K, et al. Sequence- dependence of eisplatin and 5-fluorouracil in advanced and recurrent gastric cancer[J]. Oncol Rep,2004,12(3 ) :557- 561. 被引量:1
  • 10Scagliotti GV,Parikh P,von Pawel J,et al. Phase Ⅱ study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naivepatients with advanced- stage non-small-cell lung cancer[J]. J Clin Oncol,2008, 26(21 ) :3543-3551. 被引量:1

同被引文献11

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部 意见反馈